查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301039

美国脐带血银行服务市场规模、份额和趋势分析报告：按银行类型、组成部分、州、细分市场预测，2023-2030 年

U.S. Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky, New Jersey), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

美国脐带血银行服务市场增长和趋势

美国脐带血银行服务市场规模预计到 2030 年将达到 165.9 亿美元，在市场估算和预测期内復合年增长率为 11.56%。

脐带血是造血干细胞的重要来源，可用于患有某些危及生命的疾病的儿童进行自体和同种异体移植。 同样，脐带血移植是治疗某些血液恶性肿瘤、免疫缺陷、血红蛋白病和代谢紊乱的一种有前途的治疗方法。 此外，涉及从 CB 中提取健康 T 细胞用于基于免疫疗法的癌症治疗的研究已显示出积极的结果。

这些研究表明，人们对使用 CB 治疗慢性疾病越来越感兴趣。 通过这种方式，我们正在推动市场的增长。 这种增长还归因于CB和干细胞在疾病治疗中的使用不断增加。 人们对商业银行银行业务优势的认识不断增强、服务提供商不断扩大以及保险覆盖范围不断扩大，预计将在预测期内进一步推动市场发展。 然而，高昂的存储和託收成本以及私人银行存储单位无法使用的风险预计将在一定程度上限制市场增长。 COVID-19 大流行的经济影响以及由此导致的消费者消费能力下降，导致使用 CB Bank 服务的家长人数减少。

大多数医院仍然允许由经过培训的专业人员收集 CB，但由于后勤限制、人员可用性有限、实施社交距离政策等，多种因素限制了 CB 银行的创收活动对行业产生了负面影响。 此外，一些非营利组织正在努力提高人们对CB存储的认识。 例如，2022 年 7 月，血液和生物製品促进协会 (AABB) 为此组织了多项活动，分享社交媒体图片和补充资源，强调 CB 在干细胞移植中的使用。 AABB Newsfeed 还强调了 CB 在各种研究应用中的使用。 这些努力可以提高人们对脐带血库的整体认识，并对市场增长产生积极影响。

美国脐带血银行服务市场报告亮点

  • 2022 年，私人银行部门的销售额占比最高，因为私人银行广泛的客户群可能归因于比公共银行更具吸引力的营销策略。
  • 从组成部分来看，由于美国慢性病患病率上升和出生率上升，CB 细分市场将在 2022 年占据市场主导地位。
  • 加利福尼亚州将在 2022 年占据最大的销售份额，并将在 2023 年至 2030 年期间以稳定的复合年增长率进一步扩大。
  • 其背景是该疾病的高患病率、大公司的存在、CB 在慢性病治疗中的大量使用以及政府的支持性法规。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
  • 调查假设
  • 信息获取
  • 信息或数据分析
  • 市场形成和验证
  • 市场模式
  • 世界市场：CARG 计算
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章美国脐带血银行服务市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
    • 市场挑战
  • 从用户角度分析
    • 消费者行为分析
    • 市场影响力分析
  • 美国脐带血库：市场分析工具
    • 行业分析 - 波特五力
    • 美国脐带血库 - 按因素（政治与法律、经济与技术）进行 SWOT 分析
  • 按来源（自体和同种异体）使用脐带血
    • 经批准的医疗条件
    • 潜在的医疗状况
  • COVID-19 感染的影响分析

第四章银行类型业务分析

  • 美国脐带血银行服务市场：2022 年和 2030 年银行类型变化分析
  • 私人
  • 公开
  • 混合动力

第五章组件业务分析

  • 美国脐带血银行服务市场：2022 年和 2030 年成分变化分析
  • 脐带血
  • 脐带组织
  • 胎盘

第 6 章区域业务分析

  • 美国脐带血银行服务市场：区域差异分析
  • 亚利桑那州
    • 2018-2030 年亚利桑那州市场估算和预测
    • 亚利桑那州银行类型展望
    • 亚利桑那州成分展望
  • 加利福尼亚州
    • 2018-2030 年加利福尼亚市场预估和预测
    • 加州银行类型展望
    • 加州成分股展望
  • 佛罗里达州
    • 2018-2030 年佛罗里达市场预估和预测
    • 佛罗里达银行类型展望
    • 佛罗里达成分展望
  • 肯塔基州
    • 2018-2030 年肯塔基州市场预估和预测
    • 肯塔基州银行类型展望
    • 肯塔基州组件展望
  • 新泽西州
    • 2018-2030 年新泽西市场估算和预测
    • 新泽西州银行类型展望
    • 新泽西州成分股展望
  • 德克萨斯州
    • 2018-2030 年德克萨斯州市场预估和预测
    • 德克萨斯州银行类型展望
    • 德克萨斯州成分股展望
  • 马萨诸塞州
    • 2018-2030 年马萨诸塞州市场估算和预测
    • 马萨诸塞州银行类型展望
    • 马萨诸塞州成分股前景

第 7 章：美国脐带血银行服务市场的竞争格局

  • 主要市场进入者的最新趋势和影响分析
  • 公司分类
  • 供应商情况
  • 上市公司
    • 企业市场分析
    • 竞争仪表板分析
    • 协同分析：主要交易和战略联盟
  • 私人公司
    • 主要初创企业名单
    • 企业市场分析
  • 本地网络地图
  • 公司简介
    • California Cryobank
    • Stemcyte Inc.
    • Cryo-Cell International, Inc.
    • Lifeforce Cryobank Sciences, Inc.
    • Stem Cell Cryobank Inc.
    • Norton Healthcare
    • Viacord
    • Miraclecord Inc.
    • New Jersey Cord Blood Bank
    • Carter Bloodcare
    • Cryocyte Llc
    • Americord Registry Llc
    • Maze Cord Blood
Product Code: GVR-2-68038-054-5

U.S. Cord Blood Banking Services Market Growth & Trends

The U.S. cord blood banking services market size is estimated to reach USD 16.59 billion by 2030, registering a CAGR of 11.56% during the forecast period, according to a new report by Grand View Research, Inc. Cord blood is a significant source of hematopoietic stem cells for autologous and allogeneic transplantation in children with certain fatal diseases. Similarly, CB transplantation represents a promising method for the treatment of certain hematologic malignancies, immunodeficiencies, hemoglobinopathies, and metabolic diseases. In addition, research studies involving the extraction of healthy T-cells from CB for use in immunotherapy-based cancer treatment have shown positive results.

Such studies indicate the rising focus on the use of CB for the treatment of chronic diseases. Thus, propelling the market growth. The growth can also be attributed to the increase in the use of CB & stem cells in disease treatment. Rising awareness about the benefits of CB banking, a growing range of service providers, and improving insurance coverage are likely to further drive the market during the forecast period. However, the high cost of storage & collection and the risk of non-usability of units stored with private banks are expected to limit the growth of the market to a certain extent. The impact of the COVID-19 pandemic on the economy and the resultant decrease in consumer spending power led to fewer parents using CB bank services.

Although the collection of CB by trained professionals was still allowed in most hospitals, several factors, such as logistical constraints, limited availability of staff, and implementation of social distancing policies, restricted the revenue generation activities for CB banks, which negatively affected the industry. Furthermore, several non-profit organizations are undertaking initiatives to raise awareness regarding the storage of CB. For instance, in July 2022, the Association for the Advancement of Blood & Biotherapies (AABB) organized several activities for this purpose and shared social media graphics and complementary resources highlighting CB usage in stem cell transplants. It also emphasized the use of CB in various research applications in the AABB Newsfeed. Such initiatives are boosting overall awareness about CB banking and can positively affect market growth.

U.S. Cord Blood Banking Services Market Report Highlights

  • In 2022, the private bank segment had the highest revenue share due to private banks' wide range of customers, potentially arise to their more enticing marketing strategies than public banks
  • By component, the CB segment dominated the market in 2022 due to the growing incidence of chronic diseases and the rise in the birth rate in the U.S.
  • California accounted for the largest revenue share in 2022 and will expand further at a steady CAGR from 2023 to 2030
  • This is due to the high prevalence of diseases, the presence of major companies, the high usage of CB for the treatment of chronic diseases, and supportive government regulations

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
    • 1.2.1 Information Analysis
    • 1.2.2 Market Formulation & Data Visualization
    • 1.2.3 Data Validation & Publishing
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Primary Research
  • 1.5 Information Or Data Analysis
  • 1.6 Market Formulation & Validation
  • 1.7 Market Model
  • 1.8 Global Market: CARG Calculation
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 U.S. Cord Blood Banking Services Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rising Applications Of Cord Blood For Treatment Of Various Disease Conditions
      • 3.2.1.2 Growing Awareness Regarding Cord Blood Treatments
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Costs And Probability Of Nonusage
    • 3.2.3 Market Challenges
      • 3.2.3.1 Lack Of Donor Diversity
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 U.S. Cord Blood Banking: Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's Five Forces
    • 3.4.2 U.S. Cord Blood Banking - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Utilization Of Cord Blood By Origin (Autologous Vs. Allogenic)
    • 3.5.1 Approved Medical Conditions
    • 3.5.2 Potential Medical Conditions
  • 3.6 COVID-19 Impact Analysis

Chapter 4 Bank Type Business Analysis

  • 4.1 U.S. Cord Blood Banking Services Market: Bank Type Movement Analysis, 2022 & 2030
  • 4.2 Private
    • 4.2.1 U.S. Private Bank Type Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Public
    • 4.3.1 U.S. Public Bank Type Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Hybrid
    • 4.4.1 U.S. Hybrid Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Component Business Analysis

  • 5.1 U.S. Cord Blood Banking Services Market: Component Movement Analysis, 2022 & 2030
  • 5.2 Cord Blood
    • 5.2.1 U.S. Cord Blood Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Cord Tissue
    • 5.3.1 U.S. Cord Tissue Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Placenta
    • 5.4.1 U.S. Placenta Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Regional Business Analysis

  • 6.1 U.S. Cord Blood Banking Services Market: Regional Movement Analysis
  • 6.2 Arizona
    • 6.2.1 Arizona Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Arizona Bank Type Outlook
      • 6.2.2.1 Private
      • 6.2.2.2 Public
      • 6.2.2.3 Hybrid
    • 6.2.3 Arizona Component Outlook
      • 6.2.3.1 Cord Blood
      • 6.2.3.2 Cord Tissue
      • 6.2.3.3 Placenta
  • 6.3 California
    • 6.3.1 California Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 California Bank Type Outlook
      • 6.3.2.1 Private
      • 6.3.2.2 Public
      • 6.3.2.3 Hybrid
    • 6.3.3 California Component Outlook
      • 6.3.3.1 Cord Blood
      • 6.3.3.2 Cord Tissue
      • 6.3.3.3 Placenta
  • 6.4 Florida
    • 6.4.1 Florida Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 Florida Bank Type Outlook
      • 6.4.2.1 Private
      • 6.4.2.2 Public
      • 6.4.2.3 Hybrid
    • 6.4.3 Florida Component Outlook
      • 6.4.3.1 Cord Blood
      • 6.4.3.2 Cord Tissue
      • 6.4.3.3 Placenta
  • 6.5 Kentucky
    • 6.5.1 Kentucky Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 Kentucky Bank Type Outlook
      • 6.5.2.1 Private
      • 6.5.2.2 Public
      • 6.5.2.3 Hybrid
    • 6.5.3 Kentucky Component Outlook
      • 6.5.3.1 Cord Blood
      • 6.5.3.2 Cord Tissue
      • 6.5.3.3 Placenta
  • 6.6 New Jersey
    • 6.6.1 New Jersey Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2 New Jersey Bank Type Outlook
      • 6.6.2.1 Private
      • 6.6.2.2 Public
      • 6.6.2.3 Hybrid
    • 6.6.3 New Jersey Component Outlook
      • 6.6.3.1 Cord Blood
      • 6.6.3.2 Cord Tissue
      • 6.6.3.3 Placenta
  • 6.7 Texas
    • 6.7.1 Texas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2 Texas Bank Type Outlook
      • 6.7.2.1 Private
      • 6.7.2.2 Public
      • 6.7.2.3 Hybrid
    • 6.7.3 Texas Component Outlook
      • 6.7.3.1 Cord Blood
      • 6.7.3.2 Cord Tissue
      • 6.7.3.3 Placenta
  • 6.8 Massachusetts
    • 6.8.1 Massachusetts Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2 Massachusetts Bank Type Outlook
      • 6.8.2.1 Private
      • 6.8.2.2 Public
      • 6.8.2.3 Hybrid
    • 6.8.3 Massachusetts Component Outlook
      • 6.8.3.1 Cord Blood
      • 6.8.3.2 Cord Tissue
      • 6.8.3.3 Placenta

Chapter 7 U.S. Cord Blood Banking Services Market Competitive Landscape

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2 Company Categorization
  • 7.3 Vendor Landscape
    • 7.3.1 List Of Key Distributors And Channel Partners
    • 7.3.2 Key Customers
  • 7.4 Public Companies
    • 7.4.1 Company Market Position Analysis
    • 7.4.2 Competitive Dashboard Analysis
    • 7.4.3 Synergy Analysis: Major Deals & Strategic Alliances
      • 7.4.3.1 Merger & Acquisition Deals
      • 7.4.3.2 Collaborations & Partnerships
      • 7.4.3.3 Business Expansion
  • 7.5 Private Companies
    • 7.5.1 List Of Key Emerging Companies
    • 7.5.2 Company Market Position Analysis
  • 7.6 Regional Network Map
  • 7.7 Company Profiles
    • 7.7.1 California Cryobank
      • 7.7.1.1 Company Overview
      • 7.7.1.2 Product Benchmarking
      • 7.7.1.3 Strategic Initiatives
    • 7.7.2 Stemcyte Inc.
      • 7.7.2.1 Company Overview
      • 7.7.2.2 Product Benchmarking
      • 7.7.2.3 Strategic Initiatives
    • 7.7.3 Cryo-Cell International, Inc.
      • 7.7.3.1 Company Overview
      • 7.7.3.2 Financial Performance
      • 7.7.3.3 Product Benchmarking
      • 7.7.3.4 Strategic Initiatives
    • 7.7.4 Lifeforce Cryobank Sciences, Inc.
      • 7.7.4.1 Company Overview
      • 7.7.4.2 Product Benchmarking
    • 7.7.5 Stem Cell Cryobank Inc.
      • 7.7.5.1 Company Overview
      • 7.7.5.2 Product Benchmarking
    • 7.7.6 Norton Healthcare
      • 7.7.6.1 Company Overview
      • 7.7.6.2 Product Benchmarking
    • 7.7.7 Viacord
      • 7.7.7.1 Company Overview
      • 7.7.7.2 Product Benchmarking
    • 7.7.8 Miraclecord Inc.
      • 7.7.8.1 Company Overview
      • 7.7.8.2 Product Benchmarking
    • 7.7.9 New Jersey Cord Blood Bank
      • 7.7.9.1 Company Overview
      • 7.7.9.2 Product Benchmarking
    • 7.7.10 Carter Bloodcare
      • 7.7.10.1 Company Overview
      • 7.7.10.2 Product Benchmarking
    • 7.7.11 Cryocyte Llc
      • 7.7.11.1 Company Overview
      • 7.7.11.2 Product Benchmarking
    • 7.7.12 Americord Registry Llc
      • 7.7.12.1 Company Overview
      • 7.7.12.2 Product Benchmarking
    • 7.7.13 Maze Cord Blood
      • 7.7.13.1 Company Overview
      • 7.7.13.2 Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. FDA-approved cord blood treatments
  • Table 3 Potential cord blood treatments
  • Table 4 List of key distributors and channel partners

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Penetration & growth prospect mapping, by bank type
  • Fig. 13 Penetration & growth prospect mapping, by component
  • Fig. 14 U.S. cord blood banking services market driver impact
  • Fig. 15 U.S. cord blood banking services market restraint impact
  • Fig. 16 Porter's five force analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 U.S. cord blood banking services market: Bank type outlook & key takeaways
  • Fig. 19 U.S. cord blood banking services market: Bank type movement analysis
  • Fig. 20 U.S. private bank type market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. public bank type market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. hybrid market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. cord blood banking services market: Component outlook & key takeaways
  • Fig. 24 U.S. cord blood banking services market: Component movement analysis
  • Fig. 25 U.S. cord blood market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. cord tissue market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. placenta market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 U.S. cord blood banking services market: Regional movement analysis
  • Fig. 30 Arizona market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Arizona private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Arizona public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Arizona hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Arizona cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Arizona cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Arizona placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 California market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 California private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 California public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 California hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 California cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 California cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 California placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Florida market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Florida private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Florida public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Florida hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Florida cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Florida cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Florida placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Kentucky market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kentucky private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Kentucky public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Kentucky hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Kentucky cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kentucky cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Kentucky placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 New Jersey market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 New Jersey private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 New Jersey public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 New Jersey hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 New Jersey cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 New Jersey cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 New Jersey placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Texas market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Texas private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Texas public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Texas hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Texas cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Texas cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Texas placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Massachusetts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Massachusetts private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Massachusetts public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Massachusetts hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Massachusetts cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Massachusetts cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Massachusetts placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 New developments-based initiatives by key market participants
  • Fig. 80 Participant categorization: U.S. cord blood banking services market
  • Fig. 81 Public company market position analysis, 2022
  • Fig. 82 Competitive dashboard analysis, by key market participants
  • Fig. 83 Private company market position analysis, 2022
  • Fig. 84 Regional network map